Collaborator Name Misspelled

In the Original Investigation titled “Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial,” published in the February 1, 2022, issue of JAMA, a collaborator’s

Highlights from this issue

Improvement of asymmetric thyroid eye disease with teprotumumab (see page 755) Teprotumumab, a novel IGF-1R antibody, differentially reduces proptosis in patients with asymmetric thyroid eye disease. Anterior segment optical coherence tomography and ultrasound biomicroscopy for measuring thickness of corneal and

Gene of the month: NKX3.1

NKX3.1 is a multifaceted protein with roles in prostate development and protection from oxidative stress. Acting as a pioneer factor, NKX3.1 interacts with chromatin at enhancers to help integrate androgen regulated signalling. In prostate cancer, NKX3.1 activity is frequently reduced

Highlights from this issue

Taking a second lookWarmia, Poland 1530s An extraordinary polymath called Nicolaus Copernicus is completing his work on heliocentricity, challenging (with support from both academic and theological colleagues) the ‘earth at the centre of the universe’ assumption Soho, London 1850s A

Polygenic risk scores for CARDINAL study

Nature Genetics, Published online: 05 May 2022; doi:10.1038/s41588-022-01074-3 The Cardiometabolic Disorders in African-Ancestry Populations (CARDINAL) study site is a well-powered, first-of-its-kind resource for developing, refining and validating methods for research into polygenic risk scores that accounts for local ancestry, to

Error in Table

The Review article titled “Diagnosis and Treatment of Acute Coronary Syndromes: A Review,” published in the February 15, 2022, issue of JAMA, included an error in Table 3 in which aldosterone, rather than spironolactone, was listed as a mineralocorticoid receptor

Biobanking in Latinos: current status, principles for conduct, and contribution of a new biobank, El Banco por Salud, designed to improve the health of Latino patients of Mexican ancestry with type 2 diabetes

Underserved Latino communities experience a greater burden of type 2 diabetes mellitus (T2DM) than the general population. Predictors of glycemic control are likely to include both biological/genetic and social determinants of health (SDOH). A variety of approaches have been used

WhatsApp WhatsApp'tan Bize Yazın